ETHZilla Corp — Director's Dealing 2022

Jan 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2022-01-14

Reporting Person: Gold Lawrence Marshall (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-14	Common Stock	A	4728	$3.04	Acquired	11458	Direct

Footnotes

F1: Issued in consideration for serving on the Board of Directors, as a Member of the Audit Committee and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended December 31, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.